切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2009, Vol. 03 ›› Issue (03) : 197 -200. doi: 10.3877/cma.j.issn.1674-0793.2009.03.006

论著

上皮型钙黏附素基因表达及启动子甲基化与胃癌家族遗传性
宋武1, 何裕隆1,(), 张常华1, 蔡世荣1, 周学付1, 彭建军1, 詹文华1   
  1. 1.510080 广州,中山大学附属第一医院胃肠胰外科,中山大学胃癌诊治中心
  • 收稿日期:2009-02-01 出版日期:2009-06-01
  • 通信作者: 何裕隆
  • 基金资助:
    国家自然科学基金(30571832)广东省省自然科学基金项目(7001669)中山大学附属第一医院与生命科学院合作项目(162013)

Relationship between expression of E-cadherin and its promoter methylation status in gastric carcinoma with its family gastric cancer

Wu SONG1, Yu-long HE1,(), Chang-hua ZHANG1, Shi-rong CAI1, Xue-fu ZHOU1, Jian-jun PENG1, Wen-hua ZHAN1   

  1. 1.Department of Gastrointestinoal and Pancreatic Surgery, First Affiliated Hosρital of Sun Yet-San University,Guangzhou 510080,China
  • Received:2009-02-01 Published:2009-06-01
  • Corresponding author: Yu-long HE
引用本文:

宋武, 何裕隆, 张常华, 蔡世荣, 周学付, 彭建军, 詹文华. 上皮型钙黏附素基因表达及启动子甲基化与胃癌家族遗传性[J]. 中华普通外科学文献(电子版), 2009, 03(03): 197-200.

Wu SONG, Yu-long HE, Chang-hua ZHANG, Shi-rong CAI, Xue-fu ZHOU, Jian-jun PENG, Wen-hua ZHAN. Relationship between expression of E-cadherin and its promoter methylation status in gastric carcinoma with its family gastric cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2009, 03(03): 197-200.

目的

通过检测家族遗传性胃癌和伴胃癌家族史和肿瘤家族史胃癌及散发性胃癌的E-cd的表达和启动子甲基化情况,探讨E-cd与我国家族遗传性胃癌家系的关系。

方法

采用免疫组织化学方法检测符合ICG-HGC诊断标准的家族性遗传性胃癌8例和伴胃癌家族史胃癌的30例,伴肿瘤家族史胃癌的30例,散发性胃癌20例的E-cd蛋白表达情况及基因启动子甲基化情况,进行分析,探讨家族性胃癌发生的分子遗传学基础。

结果

E-cd在各组胃癌中表达均下调,与正常组织的差异具有统计学意义。家族性遗传性胃癌中E-cd表达下调与其他胃癌组相比差异具有统计学意义。在各组中均不同程度发生E-cd基因启动子甲基化,在家族遗传性胃癌、伴胃癌家族史胃癌与其他组相比差异具有统计学意义。

结论

E-cd蛋白表达抑制在胃癌中较常见;且在家族遗传性胃癌组降低最明显,同时E-cd基因启动子区甲基化可能是导致E-cd基因表达下调的重要原因;E-cd基因可能是家族遗传性胃癌的分子遗传学基础。

Objective

To investigate the protein expression of E-cd and its promoter methylation status of family gastric cancer and gastric cancer with gastric cancer family history or other neoplasms family history,sporadic gastric cancer in order to evaluate their relationship between family heredity gastric cancer with the protein expression of E-cd and its promoter methylation status.

Methods

Eight hundreds specimen of ICG-HGC according with Internation Collaborative Group on Hereditary Gastric Cancer standard and 30 cases of gastric carcer with gastric cancer family history,and 30 case of gastric carcer with other neoplasms family history,and 20 cases of sporadic gastric cancer were studied by immunohistochemical SP method and Methylation-Specific-PCR(MSP)to explore the molecular genetics of ICG-HGC.

Results

The protein expression of E-cd were reduced or negative compare with normal tissure,especially in ICG-HGC group was significant difference with other gastric group.E-cd promoter hypermethylation was found in every gastric group.E-cd promoter hypermethylation rate in ICG-HGC and gastric cancer family history group were significant difference with gastric cancer of other neoplasms family history and sporadic gastric cancer group.

Conclusions

The positive E-cd expression is not rare in gastric cancer tissue.E-cd promoter hypermethylation is the main cause to result in down regulation E-cd expression.The protein expression of E-cd in ICG-HGC are significant reduced than other gastric group,E-cd gene can be the molecular genetics mechanistic basis of hereditary gastric cancer.

图1 胃癌标本E-cd 阴性表达和正常胃黏膜阳性表达结果
图2 甲基化特异性PGR 产物:(M 为甲基化扩增产物,大小为204 bp;U 为非甲基化扩增产物,大小为211 bp)
表1 各组胃癌免疫组化和启动子甲基化结果比较(例)
表2 E-cd 表达与E-cd 启动子甲基化的情况(例)
1
Miriam Barber,Rebecca C,Fitzgerald MA,et al.Familial gastric cancer eaetiology and ρathogenesis.Best Practice&Research Clinical Gastroenterology,2006,20(4):721-734.
2
宋武,何裕隆,张常华,等.我国家族性胃癌家系的临床病理特点及其相关肿瘤的分析.中华普通外科杂志,2008,23(4):265-269.
3
Graziano F,Humar B,Guilford P.The role of the E-cadherin gene(CDH1)in diffuse gastric cancer susceρtibility:from the laboratory to clinical practice.Ann Oncol,2003,14(12):1705-1713.
4
Kelly KF,Spring CM,Otehere AA,et al.NLS-dependent nuclear Localization of P120ctn is necessary to relieve Kaiso-mediated transcriptional repression.J Cell Sci,2004,117(Pt13):2675-2686.
5
EstellerM.Dormanthypermethylatedtumorsuppressorgenes:questions and answers.J Patho,2005,205(2):172-180.
6
Machado JC,Oliveira C,Carvalho R,et al.E-cadherin gene(E-cadherin) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.Oncogene,2001,20(12):1525-1528.
7
Zazula M,Ferreira AM,Czopek JP,et al.CDH1 gene promoter hypermethylation in gastric cancer:relationship to Goseki grading,microsat ellite instability status,and EBV invasion.Diagn Mol Pathol,2006,15(1):24-29.
8
Cheng C,Wu P,Yu J, Huang C, et al. Mechanisms of inactivation of E-cadherin in breast carcinomas:modification of the two-hit hypothesis of tumour suppressor gene.Oncogene,2001,20:3814-3823.
9
Waki T, Tamura G, Sato M, et al. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene,2003,22(26):4128-4133.
10
Miyazaki T,Murayama Y,Shinomura Y,et al.E-cadherin gene promoterhypermethylationinH.pylori-inducedenlargedfoldgastritis.Helicobacter,2007,12(5):523-531.
11
Figueiredo C,Machado JC,Pharoah P,et al.Helicobacter pylori and interleukin 1 genotyping:an opportunity to identify high-risk individuals for gastric carcinoma.J Natl Cancer Inst,2002,94(22):1680-1687.
12
Bolos V,Peinado H,Perez-Moreno MA,et al.The transcri ption factor Slug reρresses E-cadherin expression and induces epithelial to mesenchymal transitions:a comρarison with Snail and E47 repressors.J Cell Sci,2003,116(3):499-511.
13
Rios DJ,Day KC,Kuefer R,et al.The role of calρain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. J Biol Chem,2003,278(2):1372-1379.
14
Graziano F,Arduini F,Ruzzo A,et al.Combined analysis of E-cadherin gene(CDH1) promoter hy permethylation and E-cadherin protein expression in patients with gastric cancer:im plications for treatment with demethylating drugs.Ann Oncol,2004,15(3):489-492.
[1] 谭娟, 谭建新, 邵彬彬, 王艳, 许争峰. 胎儿单基因遗传病无创产前检测的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 245-250.
[2] 沈华娟, 庄剑波, 刘春. 幽门螺杆菌感染抗体分型与胃黏膜炎性病变程度及黏膜组织学变化间的相关性[J]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 156-162.
[3] 黄一博, 李至彦, 林晨, 陶亮, 王萌, 管文贤. 胃癌根治术中淋巴结示踪剂的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 586-588.
[4] 丁关棣, 黄云, 曹震, 刘刚. 胃癌根治术后感染性并发症预测:基于真实世界数据的Nomogram模型开发与验证[J]. 中华普外科手术学杂志(电子版), 2024, 18(03): 261-266.
[5] 谭智勇, 付什, 李宁, 王海峰, 王剑松. 膀胱小细胞癌发病机制及其诊疗研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 183-187.
[6] 刘锦程, 王斌, 张雯, 张明周, 刘禹, 叶东樊, 黄赞胜, 邱凌霄, 卿斌, 王创业, 王南博, 王苹, 郭宇航, 周培花, 程秋霞, 徐智. 肺泡灌洗液RASSF1A及SHOX2甲基化联合径向超声特征对肺结节性质鉴别诊断的意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 505-511.
[7] 胡海涛, 邵欣欣, 姜玉娟, 王鹏, 李维坤, 卢一鸣, 田艳涛. 十二指肠残端处理对全腹腔镜胃癌根治术后并发症的影响[J]. 中华腔镜外科杂志(电子版), 2024, 17(04): 205-209.
[8] 王泽钦, 洪军, 王雅平, 王健, 蒿汉坤. W型肝脏悬吊技术在全腹腔镜下全胃切除术中的应用[J]. 中华腔镜外科杂志(电子版), 2024, 17(04): 218-221.
[9] 李晶, 潘侠, 周芳, 汪晶, 洪佳. 普鲁卡因通过上调lncRNA DGCR5抑制胃癌细胞增殖、迁移和侵袭[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 151-158.
[10] 甘曦, 廖鑫. 胃癌旁肿瘤沉积与CT影像学特征、血清指标及病理特征的关联性分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 422-425.
[11] 苑乐添, 王艺霖, 沈子剑, 闫呈新. 血清GDF15、sB7-H1联合多层螺旋CT灌注成像技术对胃癌患者淋巴结转移的诊断价值[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 62-66.
[12] 葛雪梅. SOX与mFOLFOX6化疗方案对晚期胃癌的疗效与安全性[J]. 中华消化病与影像杂志(电子版), 2024, 14(01): 67-71.
[13] 陈学敬, 周立娟, 赵宏, 张莉, 孙组钰, 车南颖. SHOX2和RASSF1A基因甲基化检测联合细胞学检查在支气管灌洗液标本诊断肺癌中的应用价值[J]. 中华临床医师杂志(电子版), 2024, 18(02): 139-143.
[14] 张其德. 内镜下精准肌层剥离术在伴有黏膜下层纤维化/疤痕的早期胃癌治疗的作用初探(视频)[J]. 中华胃肠内镜电子杂志, 2024, 11(02): 144-144.
[15] 郭彬焰, 褚衍六. 胃癌分期评估模型的研究现状与展望[J]. 中华胃肠内镜电子杂志, 2024, 11(02): 120-122.
阅读次数
全文


摘要